Related Experiment Video
Updated: Jun 8, 2026

Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
Functional selectivity in adrenergic and angiotensin signaling systems
Chetan B Patel1, Nabila Noor, Howard A Rockman
1Duke University Medical Center, Durham, NC 27710, USA.
Functional selectivity explains how beta-blockers and angiotensin receptor blockers work beyond simple antagonism. This biased signaling through beta-arrestin pathways offers new drug development opportunities.
Area of Science:
- Pharmacology
- Molecular Biology
- Cardiovascular Medicine
Background:
- Beta-adrenergic and angiotensin II type 1A receptors are key targets for treating common diseases like hypertension and heart failure.
- Current antagonists offer benefits but may not fully explain therapeutic effects.
- Emerging concept of functional selectivity (biased agonism) suggests differential pathway modulation.
Purpose of the Study:
- To review functional selectivity of beta-adrenergic and angiotensin II type 1A receptors.
- To examine signaling via G protein-dependent and independent pathways, focusing on beta-arrestin.
- To explore implications for next-generation therapeutics.
Main Methods:
- Literature review of functional selectivity and biased signaling.
- Focus on beta-arrestin mediated pathways.
- Analysis of ligand/receptor modification effects.
Main Results:
- Functional selectivity involves differential modulation of G protein-dependent and independent pathways.
- Beta-arrestin plays a crucial role in biased signaling.
- Ligand and receptor modifications impact biased agonism.
Conclusions:
- Functional selectivity offers a more nuanced understanding of beta-blocker and angiotensin receptor blocker mechanisms.
- Biased signaling through beta-arrestin pathways presents novel therapeutic strategies.
- This paradigm shift is critical for developing next-generation cardiovascular drugs.
More Related Videos
09:51Live Cell Imaging and 3D Analysis of Angiotensin Receptor Type 1a Trafficking in Transfected Human Embryonic Kidney Cells Using Confocal Microscopy
Published on: March 27, 2017
09:08Precision Cut Lung Slices as an Efficient Tool for Ex vivo Pulmonary Vessel Structure and Contractility Studies
Published on: May 24, 2021
Related Concept Videos
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors, which are found on postsynaptic...
Dose-Response Relationship: Selectivity and Specificity
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...